WWW:www.thcl.com.au
Investor Update Presentation
ASX:THC) (OTCMKTS:HDRPF) provides the Company's latest Investor Update Presentation. Overview
- 'Farm-to-Pharma' vertical integration
- Full-scale cannabis growing facility and combined growing and R&D facility
- Pharmaceutical GMP-ready bio-pharmaceutical manufacturing facility
- Toll manufacturing capability
- Testing and product development laboratory
- Products available to Australian patients
- Established international distribution and strategic partnerships
- Revenue generating Canadian hydroponics equipment and accessory wholesaler
- Expanding global cannabis footprint across Europe as well as Canada and New Zealand
To view the full presentation, please visit:
http://abnnewswire.net/lnk/1GT64913
About The Hydroponics Company Ltd
Hydroponics Company Ltd (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) operates under a 'farm to pharma' pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes. Having secured both a significant growing capacity over two grow sites, and an industry-leading pharmaceuticals biomanufacturing facility with attached testing and product development laboratory, THC is in prime position to service both domestic patients and the export market. THC's global commercial partners operate across four continents, supporting future international growth. THC also operates a revenue generating global hydroponics business, focusing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients.
|
||
|
Related Companies
The Hydroponics Company Ltd
ABN Newswire
ANALYTICS: LOGIN HERE
